Condition: Hypertrophic Cardiomyopathy (HCM) · Left Ventricular Hypertrophy · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
By harnessing artificial intelligence to decode the 12-lead electrocardiogram, the project will enable precise ECG-based phenotyping of hypertrophic cardiomyopathy-accurately classifying septal, apical, and other morphologic subtypes-while simultaneously differentiating HCM from hypertensive heart disease, aortic stenosis, and other phenocopy disorders.
This description comes directly from the study's public registry record.
Xiaojie Xie, MD, PhD · (+86)0571-87784700 · xiexj@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Second Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07263204